Pathogen inactivation technologies: A complex but necessary debate

被引：0
|
作者：
Andreu, G. [1 ]
Cazenave, J. -P. [2 ]
Garraud, O. [3 ,4 ,5 ,6 ]
Lefrere, J. -J. [1 ,7 ]
机构：
[1] Inst Natl Transfus Sanguine, F-75015 Paris, France
[2] Etab Francais Sang Alsace, F-67065 Strasbourg, France
[3] EFS Auvergne Loire St Etienne, F-42023 St Etienne 2, France
[4] Univ Lyon, F-42023 St Etienne, France
[5] Univ St Etienne, Fac Med, F-42023 St Etienne, France
[6] Gimap EA3064, F-42023 St Etienne, France
[7] CHU Amiens, Hematol Lab, F-80054 Amiens, France
来源：
TRANSFUSION CLINIQUE ET BIOLOGIQUE | 2011年 / 18卷 / 04期
关键词：
D O I：
10.1016/j.tracli.2011.04.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：443 / 443
页数：1
相关论文
共 50 条
  • [1] Current debate on pathogen inactivation of platelet concentrates - To use or not to use?
    Hervig, Tor
    Seghatchian, Jerard
    Apelseth, Torunn Oveland
    TRANSFUSION AND APHERESIS SCIENCE, 2010, 43 (03) : 411 - 414
  • [2] Pathogen Inactivation Technologies for Cellular Blood Components: an Update
    Schlenke, Peter
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2014, 41 (04) : 309 - 325
  • [3] The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates
    Kaiser-Guignard, Julie
    Canellini, Giorgia
    Lion, Niels
    Abonnenc, Melanie
    Osselaer, Jean-Claude
    Tissot, Jean-Daniel
    BLOOD REVIEWS, 2014, 28 (06) : 235 - 241
  • [4] Pathogen Inactivation Technologies The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk
    Devine, Dana V.
    Schubert, Peter
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (03) : 609 - +
  • [5] PATHOGEN INACTIVATION
    Teo, D.
    VOX SANGUINIS, 2011, 101 : 38 - 38
  • [6] Proceedings of a consensus conference: Pathogen inactivation making decisions about new technologies
    Webert, Kathryn E.
    Cserti, Christine M.
    Hannon, Judy
    Lin, Yulia
    Pavenski, Katerina
    Pendergrast, Jacob M.
    Blajchman, Morris A.
    TRANSFUSION MEDICINE REVIEWS, 2008, 22 (01) : 1 - 34
  • [7] Pathogen inactivation/reduction technologies for platelet transfusion: Where do we stand?
    Garraud, O.
    Lozano, M.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2018, 25 (03) : 165 - 171
  • [8] Pathogen inactivation: making decisions about new technologies - Report of a consensus conference
    Klein, Harvey G.
    Anderson, David
    Bernardi, Marie-Josee
    Cable, Ritchard
    Carey, William
    Hoch, Jeffrey S.
    Robitaille, Nancy
    Sivilotti, Marco L. A.
    Smaill, Fiona
    TRANSFUSION, 2007, 47 (12) : 2338 - 2347
  • [9] MORE DEBATE NECESSARY
    BELL, BM
    NAVAL ARCHITECT, 1991, : E429 - E429
  • [10] A troubling but necessary debate
    不详
    LANCET, 2005, 366 (9494): : 1332 - 1332
12345